A brief overview of the key points discussed during a company’s quarterly earnings call, including financial performance, guidance, and management’s commentary on future outlook.
Cosmo Bio Earnings
Estimates
Actual
Y-on-Y Change
Revenue
EPS
Transcripts
Events
About Cosmo Bio Company,Limited
Cosmo Bio Company,Limited
3386
Cosmo Bio Company,Limited, together with its subsidiaries, engages in the purchase and sale of research reagents, equipment, and contract services related to life science worldwide. The company distributes antibodies, antigens, biologically active substances, enzymes, substrates, peptides, amino acids, chemicals, carbohydrates, lipids, virus components, and bacteria, as well as detection reagents, cell and tissue culture systems, and gene analysis systems; and research instruments, including electrophoresis apparatuses, cell culture labware, gene manipulation systems, and data analysis software. It also provides drug discovery and custom research services; clinical diagnostics; consigned services, such as intestinal flora analysis, tear fluid analysis, and cell assays services; and custom peptide synthesis and antibody production services. In addition, the company manufactures and sells cell/cell culture products comprising adipose tissue, bone, cartilage, tooth, pancreas, liver function, cardiovascular, immune, mesenchymal stem cells, feeder cells, tumor cell lines, macrophage-related, and coating reagents; measurement and staining kits, detection/purification kits related to neurodementia, macrophage/immune, exosome, and anti-saccharification/anti-aging; and biotechnology research equipment, such as constant-temperature transport containers, aluminum block mat heat insulation devices, and dew condensation prevention glass plate. It serves educational institutions, research organizations, and companies engaged in biological science. Cosmo Bio Company,Limited was founded in 1978 and is headquartered in Koto, Japan.
Cosmo Bio Company,Limited, together with its subsidiaries, engages in the purchase and sale of research reagents, equipment, and contract services related to life science worldwide. The company distributes antibodies, antigens, biologically active substances, enzymes,...
Cosmo Bio Company,Limited, together with its subsidiaries, engages in the purchase and sale of research reagents, equipment, and contract services related to life science worldwide. The company distributes antibodies, antigens, biologically active substances, enzymes, substrates, peptides, amino acids, chemicals, carbohydrates, lipids, virus components, and bacteria, as well as detection reagents, cell and tissue culture systems, and gene analysis systems; and research instruments, including electrophoresis apparatuses, cell culture labware, gene manipulation systems, and data analysis software. It also provides drug discovery and custom research services; clinical diagnostics; consigned services, such as intestinal flora analysis, tear fluid analysis, and cell assays services; and custom peptide synthesis and antibody production services. In addition, the company manufactures and sells cell/cell culture products comprising adipose tissue, bone, cartilage, tooth, pancreas, liver function, cardiovascular, immune, mesenchymal stem cells, feeder cells, tumor cell lines, macrophage-related, and coating reagents; measurement and staining kits, detection/purification kits related to neurodementia, macrophage/immune, exosome, and anti-saccharification/anti-aging; and biotechnology research equipment, such as constant-temperature transport containers, aluminum block mat heat insulation devices, and dew condensation prevention glass plate. It serves educational institutions, research organizations, and companies engaged in biological science. Cosmo Bio Company,Limited was founded in 1978 and is headquartered in Koto, Japan.
Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach. Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
